The book comprehensively discusses the mechanisms of pathogenesis and
drug resistance; current diagnostics landscape of four key human
pathogens; bacterial, fungal, protozoans and viral which are the causes
of major infectious diseases. It also assesses the emerging technologies
for the detection and quantification of these pathogens. Further, it
discusses the novel opportunities to fight against these infectious
diseases and to identify pertinent drug targets with novel
methodologies. It also reviews the current and future insights into the
control, elimination, and eradication of these infectious diseases.
Importantly, the book discusses the epidemiological characteristics and
various challenges in combating Ebola and Influenza diseases. Finally,
the book highlights the growing role of nanotechnology and
bioinformatics resources for combating the infectious diseases.
In summary, the book provides the mechanistic insight of the
pathogenicity, drug-resistance, therapeutic strategies and
identification of the novel drug targets of Mycobacterium
tuberculosis, Plasmodium, Candida, Hepatitis C and emerging viral
infections.